Due to the nature of the disease, triple-negative breast cancer is more challenging to treat – there are fewer treatment options available compared to other types of breast cancer3 and limited approved targeted therapies39. Surgery, chemotherapy and radiotherapy are typically prescribed.

Nonetheless, newer innovative therapies have become available in recent years to treat triple-negative breast cancer in combination with other cancer treatments40, offering patients renewed hope to fight the disease.

Chemotherapy41

Chemotherapy41

Chemotherapy can be given before or after breast surgery, depending on the characteristics of the breast cancer and your medical history.
Read More

Surgery42

Surgery42

Surgery may be performed to an area of the breast (lumpectomy or breast-conserving surgery) or the entire breast (mastectomy). The lymph nodes may also be removed to determine the extent of cancer spread.
Read More

Radiotherapy43

Radiotherapy43

Radiotherapy is often recommended after lumpectomy and may be used after a mastectomy if the cancer is large or has spread to the lymph nodes.
Read More

Targeted Therapy44

Targeted Therapy44

Targeted therapies such as antibody drug conjugates and PARP inhibitors can help treat triple-negative breast cancer.
Read More

Immunotherapy17

Immunotherapy17

Immunotherapy involves helping the body's immune system fight cancer. Immunotherapy works with the body’s natural immune system to enable it to identify and destroy cancer cells on its own.
Read More

Clinical Trials


Clinical trials are a type of well organised human research involving a group of patients who volunteer to participate in studies to test new drugs, procedures and treatments (e.g. chemotherapy, immunotherapy, targeted therapy, or procedures and behavioral intervention) to evaluate their safety and effects on human health outcomes. Clinical trials are part of a long, meticulous process, which may take many years to complete. When proven to be effective and safe, these treatments may become tomorrow’s standard of care. There have been many clinical trials on new innovator treatment for triple-negative breast cancer. Your doctor may offer you a clinical trial as a treatment option, or you can also ask your doctor if there are any clinical trials available near you.


Let’s take action to prevent

triple-negative breast cancer


Triple the Facts, Triple the Fight!


Certain innovative treatments are currently not available as a standard of care in public hospitals in Malaysia.

Learn more about how you can advocate for greater access to innovative treatment.
Learn More